Novo Nordisk reveals cyber attack: Ozempic and Wegovy maker say data breach in clinical trials


  • Novo Nordisk cyber attack exposed pseudonymized patient data from clinical trials (IDs, biomarkers, lifestyle factors)
  • The company insists that no direct PII was leaked, reducing the immediate risk of phishing or identity theft
  • Systems shut down for containment; Third-party experts investigating, core operations remain unaffected

Novo Nordisk, one of the largest pharmaceutical companies in the world, has confirmed that it recently suffered a cyber attack in which it lost sensitive data belonging to clinical trial patients.

The company claims that the data is pseudonymised and as such cannot be used in phishing scams or other follow-up attacks.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top